Background: Type 2 Diabetes Mellitus (T2DM) is a prevalent metabolic disorder associated with significant cardiovascular risk, partly due to dyslipidemia. Dyslipidemia, characterized by abnormal lipid levels, is a common complication in T2DM patients and can contribute to the development of cardiovascular and cerebrovascular diseases. Aim & Objective: To determine the prevalence of dyslipidemia in newly diagnosed type 2 diabetes mellitus patients. Methodology: This cross-sectional study included 140 patients with newly diagnosed T2DM. Lipid profiles were measured, including total cholesterol, LDL-C, HDL-C, and triglycerides. Glycemic control was assessed via HbA1c levels. Demographic data such as age, gender, and Body Mass Index (BMI) categories were recorded. The prevalence of dyslipidemia and its association with these factors were analyzed using appropriate statistical tests. Results: The study found that 71.40% of patients had dyslipidemia. Elevated triglycerides were present in 57.10% of patients, low HDL-C in 50%, elevated LDL-C in 42.90%, and elevated total cholesterol in 35.70%. Dyslipidemia was more prevalent in males (78.6%) compared to females (64.3%) and increased with age and higher BMI. Poor glycemic control (HbA1c ≥ 7%) was significantly associated with a higher prevalence of dyslipidemia (80% vs. 50% with HbA1c < 7%, p=0.02). Conclusion: The study highlights a high prevalence of dyslipidemia among newly diagnosed T2DM patients, particularly in males, older individuals, those who are overweight or obese, and those with poor glycemic control. These findings underscore the need for integrated management strategies to address both glycemic and lipid abnormalities to improve cardiovascular health in T2DM patients. Routine monitoring of blood glucose and lipid profiles is essential for early detection and intervention